| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $48M | — | — | — | — |
| Op. Income | $3M | — | — | — | — |
| Gross Margin | 61.3% | — | — | — | — |
| Net Margin | 4.2% | — | — | — | — |
| EPS (Diluted) | $0.15 | — | — | — | — |
| Free Cash Flow | $7M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $48M |
| Cost of Revenue | $19M |
| GROSS PROFIT | $29M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $17M |
| SG&A Expenses | $17M |
| Other Expenses | $9M |
| Operating Expenses | $26M |
| Cost & Expenses | $45M |
| OPERATING INCOME | $3M |
| Interest Income | $42M |
| Interest Expense | $17M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $3M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2M |
| D&A | $782.0K |
| EBIT | $3M |
| EBITDA | $4M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $48M |
| Cost of Revenue | $19M |
| GROSS PROFIT | $29M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $17M |
| SG&A Expenses | $17M |
| Other Expenses | $9M |
| Operating Expenses | $26M |
| Cost & Expenses | $45M |
| OPERATING INCOME | $3M |
| Interest Income | $42M |
| Interest Expense | $17M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $3M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2M |
| D&A | $782.0K |
| EBIT | $3M |
| EBITDA | $4M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $2M |
| Depreciation & Amortization | $782.0K |
| Stock-Based Compensation | $1M |
| Deferred Income Tax | -$139.0K |
| Other Non-Cash Items | $47.0K |
| Change in Working Capital | $4M |
| OPERATING CASH FLOW | $7M |
| Capital Expenditure | -$191.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$42M |
| Sales/Maturities of Investments | $61M |
| Other Investing Activities | -$90M |
| NET CASH FROM INVESTING | -$70M |
| Net Debt Issuance | -$1M |
| Common Stock Repurchased | -$6M |
| Common Dividends Paid | -$2M |
| Other Financing Activities | $220M |
| NET CASH FROM FINANCING | $211M |
| FREE CASH FLOW | $7M |
| Net Change in Cash | $148M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $399M |
| Short-Term Investments | $397M |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $796M |
| PP&E (Net) | $11M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $2.3B |
| Tax Assets | $0 |
| Other Non-Current Assets | $159M |
| TOTAL NON-CURRENT ASSETS | $2.4B |
| TOTAL ASSETS | $3.2B |
| Account Payables | $0 |
| Short-Term Debt | $3M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $2.8B |
| TOTAL CURRENT LIABILITIES | $2.8B |
| Long-Term Debt | $74M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $40M |
| TOTAL NON-CURRENT LIABILITIES | $114M |
| TOTAL LIABILITIES | $2.9B |
| Common Stock | $14M |
| Additional Paid-In Capital | $166M |
| Retained Earnings | $173M |
| Treasury Stock | -$23M |
| Accum. Other Comp. Income | -$28M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $302M |
| Minority Interest | $0 |
| TOTAL EQUITY | $302M |
| TOTAL LIABILITIES & EQUITY | $3.2B |
| Total Debt | $77M |
| Net Debt | -$322M |
